Scribeberry is an advanced AI-powered medical scribe designed for clinicians. It automates clinical documentation by listening to patient encounters, generating structured notes, and integrating seamlessly with EMRs. This saves healthcare providers hours daily, reduces burnout, and allows for greater focus on patient care.
ScribeMD is a HIPAA-compliant AI medical scribe designed for healthcare professionals. It automates clinical note-taking by listening to patient interactions, transcribing them, and generating structured documentation. This allows doctors to reduce administrative workload, save significant time per patient, and focus more on patient care.
Scribeberry is an advanced AI-powered medical scribe designed for clinicians. It automates clinical documentation by listening to patient encounters, generating structured notes, and integrating seamlessly with EMRs. This saves healthcare providers hours daily, reduces burnout, and allows for greater focus on patient care.
ScribeMD is a HIPAA-compliant AI medical scribe designed for healthcare professionals. It automates clinical note-taking by listening to patient interactions, transcribing them, and generating structured documentation. This allows doctors to reduce administrative workload, save significant time per patient, and focus more on patient care.
| Feature | Scribeberry | ScribeMD |
|---|---|---|
| Primary category | Virtual Scribe | Medical Documentation |
| Added | 2025-08-03 | 2025-08-10 |
| Pricing | Freemium | Paid |
| Official website | scribeberry.com | www.scribemd.ai |
| Product type | Website | Website |
| Performance data | ||
| User rating | Not verified | Not verified |
| Comments | 0 | 0 |
| Monthly visits | 67.5K | 4.5K |
| Monthly growth | 1.2% | 21.4% |
| Favorites | 113 | 104 |
| Details | View details | View details |
Compare Scribeberry and ScribeMD by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the Scribeberry vs ScribeMD monthly traffic comparison, Scribeberry currently shows 67.5K visits and ScribeMD shows 4.5K; Scribeberry has about 14.9 times the visible traffic of ScribeMD, an absolute difference of about 63K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇨🇦Canada | 93.87% | 63.4K |
| 🇺🇸United States | 5.25% | 3.5K |
| 🇮🇳India | 0.78% | 527 |
| 🇷🇺Russia | 0.1% | 68 |
| Source type | Percentage | Traffic |
|---|---|---|
| Direct | 70.25% | 47.4K |
| Referral | 29.75% | 20.1K |
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 84.66% | 3.8K |
| 🇪🇸Spain | 14.21% | 644 |
| 🇮🇳India | 1.13% | 51 |
This in-depth Scribeberry vs ScribeMD comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Scribeberry is primarily listed under “Virtual Scribe”, while ScribeMD is primarily listed under “Medical Documentation”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Scribeberry: Virtual Scribe; ScribeMD: Medical Documentation); Pricing (Scribeberry: Freemium; ScribeMD: Paid); Monthly visits (Scribeberry: 67.5K; ScribeMD: 4.5K); Monthly growth (Scribeberry: 1.2%; ScribeMD: 21.4%); Favorites (Scribeberry: 113; ScribeMD: 104). These facts are more useful for selection than brand visibility alone.
In the Scribeberry vs ScribeMD monthly traffic comparison, Scribeberry currently shows 67.5K visits and ScribeMD shows 4.5K; Scribeberry has about 14.9 times the visible traffic of ScribeMD, an absolute difference of about 63K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
If public market visibility is an important first-pass criterion, investigate Scribeberry first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
Scribeberry and ScribeMD currently overlap in shared categories: Medical Documentation and Transcription; shared tags: clinical documentation, doctor productivity, healthcare AI, HIPAA compliant, and medical scribe. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Scribeberry's unique categories/tags are Virtual Scribe, burnout prevention, EMR integration, medical notes, and transcription; ScribeMD's are Automation, EMR automation, medical transcription, patient notes, and voice to text. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
Scribeberry has no verified rating, 0 comments, 113 favorites, and 106 likes；ScribeMD has no verified rating, 0 comments, 104 favorites, and 124 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put Scribeberry on the priority trial list when the task aligns with “Virtual Scribe” and especially Virtual Scribe, burnout prevention, EMR integration, medical notes, and transcription. This follows recorded positioning and does not imply unlisted capabilities are absent.
Scribeberry also currently records: pricing is freemium, product type is website, 67.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put ScribeMD on the priority trial list when the task aligns with “Medical Documentation” and especially Automation, EMR automation, medical transcription, patient notes, and voice to text. This follows recorded positioning and does not imply unlisted capabilities are absent.
ScribeMD also currently records: pricing is paid, product type is website, 4.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Scribeberry and ScribeMD, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
